- Home
- AR vs RVTY Comparison
AR vs RVTY Comparison
Compare AR & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AR | RVTY |
|---|---|---|
| Founded | 2002 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Laboratory Analytical Instruments |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 11.8B |
| IPO Year | 2013 | 1994 |
Fundamental Metrics
Financial Performance| Metric | AR | RVTY |
|---|---|---|
| Price | $37.00 | $92.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 16 |
| Target Price | $46.69 | ★ $111.87 |
| AVG Volume (30 Days) | ★ 5.8M | 873.4K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.31% |
| EPS Growth | ★ 1027.78 | N/A |
| EPS | 2.03 | ★ 2.07 |
| Revenue | ★ $5,275,823,000.00 | $3,311,822,000.00 |
| Revenue This Year | $28.71 | $6.34 |
| Revenue Next Year | $5.50 | $5.14 |
| P/E Ratio | ★ $18.68 | $43.36 |
| Revenue Growth | ★ 21.97 | N/A |
| 52 Week Low | $29.10 | $81.36 |
| 52 Week High | $45.75 | $118.30 |
Technical Indicators
Market Signals| Indicator | AR | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 35.39 | 56.20 |
| Support Level | $32.71 | $88.73 |
| Resistance Level | $38.18 | $95.90 |
| Average True Range (ATR) | 1.54 | 3.04 |
| MACD | -0.91 | 1.05 |
| Stochastic Oscillator | 0.28 | 91.76 |
Price Performance
Historical ComparisonAbout AR Antero Resources Corporation
Antero Resources, based in Denver, explores for and produces natural gas and natural gas liquids in the United States and Canada. At the end of 2025, the company reported proven reserves of 19.1 trillion cubic feet of natural gas equivalent. Production averaged approximately 3,442 million cubic feet of equivalent per day in 2025 at a ratio of 35% liquids and 65% natural gas.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.